IPI Legacy Liquidation Co Temettü
Temettü kriter kontrolleri 0/6
IPI Legacy Liquidation Co does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
20.6%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | 20.6% |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | n/a |
| Ödeme oranı | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Investors Still Aren't Entirely Convinced By Impel Pharmaceuticals Inc.'s (NASDAQ:IMPL) Revenues Despite 50% Price Jump
Apr 17
The Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 30Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Analysts Just Slashed This Year's Revenue Estimates By 12%
Mar 26Impel NeuroPharma GAAP EPS of -$1.09 misses by $0.04, revenue of $2.8M misses by $1.04M
Aug 15Impel stock rises as dosing begins in mid-stage trial of INP105 for agitation in autistic people
Jul 19Impel Pharmaceuticals: Under The Radar Despite Upside Potential
Jun 28Impel NeuroPharma reports Q1 results
Jun 07Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if IMPL.Q's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if IMPL.Q's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
| IPI Legacy Liquidation Co Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (IMPL.Q) | n/a |
| Pazarın Alt %25'i (US) | 1.5% |
| Pazarın En İyi %25'i (US) | 4.5% |
| Sektör Ortalaması (Biotechs) | 2.2% |
| Analist tahmini (IMPL.Q) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate IMPL.Q's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate IMPL.Q's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate IMPL.Q's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as IMPL.Q has not reported any payouts.